A new fetal RHD genotyping test: Costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales

Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation

(2014) H Pilgrim et al.   HEALTH TECHNOLOGY ASSESSMENT

Prevalence of RhD Variants, Confirmed by Molecular Genotyping, in a Multiethnic Prenatal Population

(2010) Dehua Wang et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn

(2008) B. M. Kumpel   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Non-invasive fetal RHD genotyping tests: A systematic review of the quality of reporting of diagnostic accuracy in published studies

(2008) Karoline Freeman et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Non-invasive prenatal diagnosis and determination of fetal Rh status

(2008) C. Ellen van der Schoot et al.   Seminars in Fetal & Neonatal Medicine

The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible

(2008) Sina P. Müller et al.   TRANSFUSION